Medical device registration in Indonesia is a required step before any product can enter the market. While the framework is clearly defined, many businesses still face delays due to misalignment in classification, documentation, or local setup.
In practice, the process is not only about obtaining approval. It also affects how a product is introduced, distributed, and managed in the Indonesian market.
The Ministry of Health primarily governs medical device regulation in Indonesia. The framework is based on several key regulations that define licensing, distribution, and product standards. Key regulations include:
This regulatory framework is supported by a digital registration system managed by the Ministry of Health, where all medical device applications are submitted and evaluated.
A medical device must be registered before it can be imported, distributed, or sold in Indonesia. This applies to both locally manufactured and imported products.
Approval is granted through a distribution permit, commonly referred to as NIE (Nomor Izin Edar), issued by the Ministry of Health. Without this approval:
For many companies, this becomes the first regulatory step in market entry, though the structure behind it often requires more careful planning than expected.
Once the requirement is established, the next step is to understand the requirements for registering a medical device in Indonesia. The process is structured, but most delays come from gaps in preparation rather than the system itself.
Medical devices are classified by risk levels (Class A to D), which determines the level of evaluation and the expected timeline. Higher-risk classifications generally require more extensive technical documentation and review.
Foreign manufacturers cannot register a medical device directly. A locally licensed company must be appointed as the registration holder and serve as the point of contact with the authority. This structure also affects control over product registration and future distribution decisions.
A complete dossier is required, typically covering product specifications, intended use, and supporting technical or clinical data, depending on the classification. Inconsistent or incomplete documentation is one of the most common causes of delay during evaluation.
Read more: The economic impact of foreign investment in Indonesia
Product labelling and instructions for use must be available in Bahasa Indonesia. This requirement applies even if the product has already been approved in other markets with different labelling standards.
The appointed local party must meet distribution standards, including proper certification and licensing to handle medical devices. This ensures that the product is managed in accordance with local quality and safety requirements.
Halal certification is generally not required for most medical devices. However, products containing animal-derived materials or those with specific clinical applications may require further assessment under Indonesia's halal regulations.
After preparing the key requirements, the registration of a medical device follows a structured process through the Ministry of Health system. While the steps are straightforward, the sequence and alignment between documents play an important role in how smoothly the process moves.
The process begins by appointing a local entity as the registration holder. This party will be responsible for submitting the application and communicating with the authority.
All administrative and technical documents are compiled based on product classification. At this stage, consistency across documents, such as product name, specifications, and intended use, is critical.
The application is submitted electronically through the Ministry of Health's registration platform. Any missing or unclear information may trigger queries during evaluation.
The authority reviews the submitted medical device based on its classification and supporting data. Additional clarification or document revisions may be requested during this stage.
Once approved, the medical device is granted a distribution permit (NIE), allowing it to be imported and distributed in Indonesia.
Delays typically arise from evaluation gaps, not the system itself. Early alignment of classification, documentation, and local structure minimizes review discrepancies.
The time required to register a medical device in Indonesia largely depends on its classification. Higher-risk devices generally undergo a more detailed evaluation, which can extend the review period.
| Classification | Estimated Timeline |
| Class A (Low Risk) | 1–2 months |
| Class B (Low–Moderate Risk) | 2–3 months |
| Class C (Moderate–High Risk) | 3–6 months |
| Class D (High Risk) | 6–12 months |
While official processing timelines may be shorter under ideal conditions, actual timelines often vary depending on documentation of readiness and review complexity.
While the registration framework for medical devices in Indonesia is clearly defined, challenges often arise during execution. These issues are typically not caused by the system itself, but by gaps in preparation or misalignment between key components.
Read more: PPh 29 in Indonesia: Tax underpayment guide for companies
Some of the more common challenges include:
Taking a structured approach early can help reduce delays and maintain better control over the introduction and management of the medical device in Indonesia.
Bringing a medical device into Indonesia involves more than completing the registration process. Early decisions around structure, documentation, and local setup can influence how smoothly the product enters and operates in the market.
Ascentium Indonesia supports businesses through each stage of the process with:
With the right preparation, medical device registration can be managed more efficiently while minimizing disruptions.